Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,816 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

NCT06173518

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +24 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Methodist Children's Hospital San Antonio, Texas, United States
  • Primary Children's Hospital Salt Lake City, Utah, United States
  • Hospital Vall d'Hebron Barcelona, Spain
View Trial Details
Recruiting

A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

NCT05334823

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Beijing Children's Hospital.Capital Medical University Beijing, Beijing Municipality, China
  • Beijing GoBroad Boren Hospital Beijing, Beijing Municipality, China
  • Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View all 16 locations
View Trial Details
Recruiting

Study of Out of Specification for Tisagenlecleucel

NCT04094311

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations
  • Novartis Investigative Site Hamilton, Ontario, Canada
  • Novartis Investigative Site Ottawa, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 55 locations
View Trial Details
Recruiting

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

NCT03104491

Conditions
Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

NCT01949129

Conditions
Acute Lymphoblastic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Hospital de Pediatria "Juan P. Garrahan" Combate de Los Pozos N°1800 CABA Buenos Aires, Argentina
  • Hospital Sor Maria Ludovica, Department Hematology Stem Cell Transplant Unit La Plata, Argentina
  • Children's Cancer Centre The Royal Children's Hospital Melbourne, Australia
  • Princess Margaret Hospital for Children Perth, Australia
View all 119 locations
View Trial Details

Related conditions